General Information
Drug ID
DR00114
Drug Name
CMP-sialic acid
Synonyms
(2R,4S,5R,6R)-2-[({[(2R,3S,4R,5R)-5-(4-amino-2-oxo-1,2-dihydropyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methoxy}(hydroxy)phosphoryl)oxy]-5-acetamido-4-hydroxy-6-[(1R,2R)-1,2,3-trihydroxypropyl]oxane-2-carboxylic acid; 3063-71-6; CHEBI:16556; CMP acetylneuraminic acid; CMP-N-acetyl-beta-neuraminate; CMP-N-acetylneuraminate; CMP-NeuNAc; CMP-Sialic acid; CYTIDINE-5'-MONOPHOSPHATE-5-N-ACETYLNEURAMINIC ACID; Cmp-D-N-acetylneuraminic acid; Cmp-nana; NCC; cytidine monophosphate N-acetylneuraminic acid
Drug Type
Small molecular drug
Indication Discovery agent [ICD11: N.A.] Investigative
Structure
3D MOL 2D MOL
Formula
C20H31N4O16P
Canonical SMILES
CC(=O)NC1C(CC(OC1C(C(CO)O)O)(C(=O)O)OP(=O)(O)OCC2C(C(C(O2)N3C=CC(=NC3=O)N)O)O)O
InChI
InChI=1S/C20H31N4O16P/c1-7(26)22-12-8(27)4-20(18(32)33,39-16(12)13(29)9(28)5-25)40-41(35,36)37-6-10-14(30)15(31)17(38-10)24-3-2-11(21)23-19(24)34/h2-3,8-10,12-17,25,27-31H,4-6H2,1H3,(H,22,26)(H,32,33)(H,35,36)(H2,21,23,34)/t8-,9+,10+,12+,13+,14+,15+,16+,17+,20+/m0/s1
InChIKey
TXCIAUNLDRJGJZ-BILDWYJOSA-N
CAS Number
CAS 22-12-8
Pharmaceutical Properties Molecular Weight 614.5 Topological Polar Surface Area 321
Heavy Atom Count 41 Rotatable Bond Count 11
Hydrogen Bond Donor Count 10 Hydrogen Bond Acceptor Count 16
XLogP
-6.7
PubChem CID
448209
PubChem SID
10300185 , 104639130 , 126523855 , 129326585 , 135676661 , 137022976 , 137244515 , 14789598 , 16900077 , 178101378 , 226494059 , 252347530 , 3428 , 36890135 , 78312682 , 7886445 , 7889315 , 8145541 , 831309 , 92093453
ChEBI ID
ChEBI:16556
TTD Drug ID
D07THV
DT(s) Transporting This Drug CST Transporter Info CMP-sialic acid transporter Substrate [1]
References
1 Disease mutations in CMP-sialic acid transporter SLC35A1 result in abnormal -dystroglycan O-mannosylation, independent from sialic acid. Hum Mol Genet. 2015 Apr 15;24(8):2241-6.

If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.